ExodusPoint Capital Management’s Alamar Biosciences ALMR Stock Holding History

ExodusPoint Capital Management’s Portfolio ALMR Stock Details ALMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.73M	Buy	+100,691	New	+$2.28M	0.02%	699

Other funds holding ALMR

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ExodusPoint Capital Management's ALMR Position: Q2 2026 in Review

ExodusPoint Capital Management opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 100,691 shares worth $2.73M. The stake represents 0.02% of the portfolio and ranks #699 among its holdings.

86 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

ExodusPoint Capital Management held 100,691 shares of Alamar Biosciences worth $2.73M as of Q2 2026.
Alamar Biosciences was a new ExodusPoint Capital Management position in Q2 2026.
Alamar Biosciences made up 0.02% of ExodusPoint Capital Management's portfolio in Q2 2026, its #699 holding.
86 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.